• Je něco špatně v tomto záznamu ?

Botulinum toxin treatment of freezing of gait in Parkinson's disease patients as reflected in functional magnetic resonance imaging of leg movement

M. Vastik, P. Hok, P. Hlustik, P. Otruba, Z. Tüdös, P. Kanovsky,

. 2016 ; 37 (2) : 147-53.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19001383

BACKGROUND: Freezing of gait (FOG) is a common disabling symptom of (in) Parkinson's disease (PD). The mechanism of FOG is (in) not clearly understood. We investigated the clinical effect and changes of the activity of the sensorimotor system using repeated functional MRI (fMRI) before and after application of botulinum toxin in Parkinson's disease patients with FOG. METHODS: We investigated 20 patients with PD, 10 with FOG and 10 without FOG. PD patients with FOG were treated with intramuscular application of botulinum toxin type A into the tensor fasciae latae muscle bilaterally. The clinical effect of treatment was assessed using FOG questionnaire, "Time up and go" test, UPDRS, Hoehn and Yahr staging, Clinical global impression scale. Activation of the sensorimotor system was studied using BOLD fMRI of the whole brain during repetitive abduction - adduction of each leg interleaved with rest. The clinical (in the FOG group) and imaging (in both groups) examination was repeated after a four-week interval. RESULTS: In the FOG group, the FOG questionnaire has shown a decline of scores after application of botulinum toxin that suggests possible effect of botulinum toxin on freezing of gait. In fMRI results, both groups manifested reduction of the sensorimotor network activated with leg movement, however, the FOG group also showed increased activation in cerebellar vermis and nuclei, in dorsal pons and in medulla after treatment. CONCLUSION: Alleviation of the FOG in PD patients by botulinum toxin seems to be reflected in the functional participation of the cerebellum and its projections as seen by fMRI.

000      
00000naa a2200000 a 4500
001      
bmc19001383
003      
CZ-PrNML
005      
20190115103736.0
007      
ta
008      
190107s2016 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)27179579
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Vastik, Miroslav $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
245    10
$a Botulinum toxin treatment of freezing of gait in Parkinson's disease patients as reflected in functional magnetic resonance imaging of leg movement / $c M. Vastik, P. Hok, P. Hlustik, P. Otruba, Z. Tüdös, P. Kanovsky,
520    9_
$a BACKGROUND: Freezing of gait (FOG) is a common disabling symptom of (in) Parkinson's disease (PD). The mechanism of FOG is (in) not clearly understood. We investigated the clinical effect and changes of the activity of the sensorimotor system using repeated functional MRI (fMRI) before and after application of botulinum toxin in Parkinson's disease patients with FOG. METHODS: We investigated 20 patients with PD, 10 with FOG and 10 without FOG. PD patients with FOG were treated with intramuscular application of botulinum toxin type A into the tensor fasciae latae muscle bilaterally. The clinical effect of treatment was assessed using FOG questionnaire, "Time up and go" test, UPDRS, Hoehn and Yahr staging, Clinical global impression scale. Activation of the sensorimotor system was studied using BOLD fMRI of the whole brain during repetitive abduction - adduction of each leg interleaved with rest. The clinical (in the FOG group) and imaging (in both groups) examination was repeated after a four-week interval. RESULTS: In the FOG group, the FOG questionnaire has shown a decline of scores after application of botulinum toxin that suggests possible effect of botulinum toxin on freezing of gait. In fMRI results, both groups manifested reduction of the sensorimotor network activated with leg movement, however, the FOG group also showed increased activation in cerebellar vermis and nuclei, in dorsal pons and in medulla after treatment. CONCLUSION: Alleviation of the FOG in PD patients by botulinum toxin seems to be reflected in the functional participation of the cerebellum and its projections as seen by fMRI.
650    _2
$a botulotoxiny $x terapeutické užití $7 D001905
650    _2
$a chůze (způsob) $7 D005684
650    _2
$a neurologické poruchy chůze $x farmakoterapie $x etiologie $7 D020233
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a Parkinsonova nemoc $x farmakoterapie $x patofyziologie $7 D010300
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hok, Pavel $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
700    1_
$a Hlustik, Petr $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
700    1_
$a Otruba, Pavel $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
700    1_
$a Tüdös, Zbyněk $u Department of Radiology, Palacky University Medical School and University Hospital, Czech Republic.
700    1_
$a Kanovsky, Petr $u Department of Neurology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 37, č. 2 (2016), s. 147-53
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27179579 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190115103947 $b ABA008
999    __
$a ok $b bmc $g 1365231 $s 1039506
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 37 $c 2 $d 147-53 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...